RRRobert C. Rickert

Robert C. Rickert

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Robert C. Rickert has a total of 33 co-authors. Here are the top co-authors by number of shared publications:

  • Matthew H. Cato

    Program on Immunity and Pathogenesis, Sanford-Burnham Medical Research Institute, La Jolla, CA 92037; and

    5 shared publications
  • Ana V. Miletic

    Program on Inflammatory Diseases, Infectious and Inflammatory Diseases Center, Sanford-Burnham Medical Research Institute, 10901 North Torrey Pines Road, La Jolla, CA 92037 USA

    3 shared publications
  • Julia Jellusova

    Program on Inflammatory Diseases, Infectious and Inflammatory Diseases Center, Sanford-Burnham Medical Research Institute, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA

    3 shared publications
  • Irene W. Yau

    Program on Inflammatory Diseases, Sanford-Burnham Medical Research Institute, La Jolla, CA 92037, USA

    2 shared publications
  • Sidne A. Omori

    Program on Inflammatory Disease Research, Infectious and Inflammatory Disease Center, and Program of Signal Transduction, Cancer Center, Sanford-Burnham Medical Research Institute, La Jolla, California 92037

    2 shared publications
  • Suresh K. Chintalapati

    Program on Inflammatory Disease Research, Infectious and Inflammatory Disease Center, and Program of Signal Transduction, Cancer Center, Sanford-Burnham Medical Research Institute, La Jolla, California 92037

    2 shared publications

Latest Publications

  • PDK1 regulates B cell differentiation and homeostasis

    by Gisele V. Baracho, Matthew H. Cato, Zilu Zhu, Olav R. Jaren, Elias Hobeika, Michael Reth, Robert C. Rickert

    Significance: Phosphatidyl inositol-3 kinase (PI3K) activity is central to B lymphocyte survival, growth, and differentiation. Recent clinical studies also indicate that inhibiting the activity of the PI3Kδ isoform will be effective in treating human B cell malignancies. Here we focus on the B cell-specific role of the Ser/Thr kinase phosphoinositide-dependent kinase 1 (PDK1), a pivotal downstream effector of PI3K signaling that is required for the activation of most members of the AGC kinase family (e.g., Akt, S6K, RSK, PKC). Using conditional gene-targeting approaches, we show that the B cell receptor and a subset of cytokine receptors require PDK1 for B cell generation in the bone marrow as well as for mature B cell survival and activation.


  • Open Access

    Context-Specific BAFF-R Signaling by the NF-κB and PI3K Pathways

    by Julia Jellusova, Ana V. Miletic, Matthew H. Cato, Wai-Wai Lin, Yinling Hu, Gail A. Bishop, Mark J. Shlomchik, Robert C. Rickert


  • Censoring of Self-Reactive B Cells by Follicular Dendritic Cell–Displayed Self-Antigen

    by Irene W. Yau, Matthew H. Cato, Julia Jellusova, Tatiana Hurtado de Mendoza, Robert Brink, Robert C. Rickert

    In the secondary lymphoid organs, intimate contact with follicular dendritic cells (FDCs) is required for B cell retention and Ag-driven selection during the germinal center response. However, selection of self-reactive B cells by Ag on FDCs has not been addressed. To this end, we generated a mouse model to conditionally express a membrane-bound self-antigen on FDCs and to monitor the fate of developing self-reactive B cells. In this article, we show that self-antigen displayed on FDCs mediates effective elimination of self-reactive B cells at the transitional stage. Notwithstanding, some self-reactive B cells persist beyond this checkpoint, showing evidence of Ag experience and intact proximal BCR signaling, but they are short-lived and unable to elicit T cell help. These results implicate FDCs as an important component of peripheral B cell tolerance that prevents the emergence of naive B cells capable of responding to sequestered self-antigens.


  • New insights into pre-BCR and BCR signalling with relevance to B cell malignancies

    by Robert C. Rickert

    The B cell receptor (BCR) and its precursor (pre-BCR) control B cell homeostasis, differentiation and function. Moreover, aberrant pre-BCR and BCR signalling have a central role in B cell neoplasia; for example, enhanced positive signalling or disrupted negative signalling downstream of the pre-BCR promotes B cell acute lymphocytic leukaemia. The emerging distinctions between tonic and chronic active BCR signalling have contributed to the identification of oncogenic targets downstream of BCR signalling in mature B cell neoplasms. Indeed, the encouraging results of several ongoing clinical trials that target the activity of phosphoinositide 3-kinase δ-isoform (PI3Kδ), Bruton tyrosine kinase (BTK) or spleen tyrosine kinase (SYK) downstream of the BCR highlight the therapeutic potential of inhibiting BCR signalling.


  • Mousing around with caspases and IAPs

    by Robert C. Rickert, Guy S. Salvesen, Carl F. Ware

    In a paper in this issue of the Biochemical Journal that questions the role of c-IAP1 (cellular inhibitor of apoptosis 1) in inflammation, new results from the Duckett laboratory remind us of the importance of truly knowing the mice we depend on. It turns out that c-IAP1 is tightly linked to caspase 11 and cannot be segregated by recombination. This disturbing result implies that immune functions ascribed to c-IAP1 may be due to the caspase 11 mutation that is co-inherited with the locus.


  • Signaling by the tumor necrosis factor receptor superfamily in B‐cell biology and disease

    by Robert C. Rickert, Julia Jellusova, Ana V. Miletic

    Summary:  Members of the tumor necrosis factor receptor superfamily (TNFRSF) participate prominently in B‐cell maturation and function. In particular, B‐cell activating factor belonging to the TNF family receptor (BAFF‐R), B‐cell maturation antigen (BCMA), and transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) play critical roles in promoting B‐cell survival at distinct stages of development by engaging a proliferation‐inducing ligand (APRIL) and/or BAFF. CD40 is also essential for directing the humoral response to T‐cell‐dependent antigens. Signaling by the TNFRSF is mediated primarily, albeit not exclusively, via the TNFR‐associated factor (TRAF) proteins and activation of the canonical and/or non‐canonical nuclear factor‐κB (NF‐κB) pathways. Dysregulated signaling by TNFRSF members can promote B‐cell survival and proliferation, causing autoimmunity and neoplasia. In this review, we present a current understanding of the functions of and distinctions between APRIL/BAFF signaling by their respective receptors expressed on particular B‐cell subsets. These findings are compared and contrasted with CD40 signaling, which employs similar signaling conduits to achieve distinct cellular outcomes in the context of the germinal center response. We also underscore how new findings and conceptual insights into TNFRSF signaling are facilitating the understanding of B‐cell malignancies and autoimmune diseases.


  • Magnetic-based purification of untouched mouse germinal center B cells for ex vivo manipulation and biochemical analysis

    by Matthew H Cato, Irene W Yau, Robert C Rickert

    Detailed biochemical analysis of unmanipulated germinal center (GC) B cells has not been achieved. Previously, we designed and used a simple, economical and new magnetic bead separation scheme for the purification of 'untouched' mature GC and non-GC B cells from the spleens of immunized mice and reported the first biochemical assessment of the signaling cascades that contribute to cyclin D stability and GC B cell proliferation. Here we provide a detailed protocol for the method we used, which involves preparing single-cell suspension from the spleens of immunized mice, followed by labeling of nontarget cells with biotinylated antibodies specific for CD43, CD11c and IgD (for GC enrichment) or GL7 (for non-GC enrichment); these steps are followed by cell depletion using standard magnetic bead technology. This protocol can yield GC and non-GC B cells with purities exceeding 90%. The sorting process can be carried out in ∼1 h and provides a population of GC B cells of sufficient purity and quantity to allow ex vivo manipulation, including biochemical and genetic analysis as well as cell culture.


  • Cyclin D3 Is Selectively Required for Proliferative Expansion of Germinal Center B Cells

    by Matthew H. Cato, Suresh K. Chintalapati, Irene W. Yau, Sidne A. Omori, Robert C. Rickert

    The generation of robust T-cell-dependent humoral immune responses requires the formation and expansion of germinal center structures within the follicular regions of the secondary lymphoid tissues. B-cell proliferation in the germinal center drives ongoing antigen-dependent selection and the generation of high-affinity class-switched plasma and memory B cells. However, the mechanisms regulating B-cell proliferation within this microenvironment are largely unknown. Here, we report that cyclin D3 is uniquely required for germinal center progression. Ccnd3(-/-) mice exhibit a B-cell-intrinsic defect in germinal center maturation and fail to generate an affinity-matured IgG response. We determined that the defect resulted from failed proliferative expansion of GL7(+) IgD(-) PNA(+) B cells. Mechanistically, sustained expression of cyclin D3 was found to be regulated at the level of protein stability and controlled by glycogen synthase kinase 3 in a cyclic AMP-protein kinase A-dependent manner. The specific defect in proliferative expansion of GL7(+) IgD(-) PNA(+) B cells in Ccnd3(-/-) mice defines an underappreciated step in germinal center progression and solidifies a role for cyclin D3 in the immune response, and as a potential therapeutic target for germinal center-derived B-cell malignancies.


  • Open Access

    Coordinate suppression of B cell lymphoma by PTEN and SHIP phosphatases

    by Ana V. Miletic, Amy N. Anzelon-Mills, David M. Mills, Sidne A. Omori, Irene M. Pedersen, Dong-Mi Shin, Jeffrey V. Ravetch, Silvia Bolland, Herbert C. Morse, Robert C. Rickert

    The inositol phosphatases phosphatase and tensin homologue (PTEN) and Src homology 2 domain–containing inositol phosphatase (SHIP) negatively regulate phosphatidylinositol-3-kinase (PI3K)–mediated growth, survival, and proliferation of hematopoietic cells. Although deletion of PTEN in mouse T cells results in lethal T cell lymphomas, we find that animals lacking PTEN or SHIP in B cells show no evidence of malignancy. However, concomitant deletion of PTEN and SHIP (bPTEN/SHIP−/−) results in spontaneous and lethal mature B cell neoplasms consistent with marginal zone lymphoma or, less frequently, follicular or centroblastic lymphoma. bPTEN/SHIP−/− B cells exhibit enhanced survival and express more MCL1 and less Bim. These cells also express low amounts of p27kip1 and high amounts of cyclin D3 and thus appear poised to undergo proliferative expansion. Unlike normal B cells, bPTEN/SHIP−/− B cells proliferate to the prosurvival factor B cell activating factor (BAFF). Interestingly, although BAFF availability may promote lymphoma progression, we demonstrate that BAFF is not required for the expansion of transferred bPTEN/SHIP−/− B cells. This study reveals that PTEN and SHIP act cooperatively to suppress B cell lymphoma and provides the first direct evidence that SHIP is a tumor suppressor. As such, assessment of both PTEN and SHIP function are relevant to understanding the etiology of human B cell malignancies that exhibit augmented activation of the PI3K pathway.